Achieve Life Sciences Inc. (ACHV)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Propel Bio Management

Leen Kawas And Richard Kayne

2,453,092 $8,634,884 8.57%
2.
Nantahala Capital Management

Wilmot B. Harkey And Daniel Mack

654,000 $2,302,080 0.09%
3. 421,000 $1,481,920 -11% 0%
4. 248,099 $873,308 0.02%
5. 61,160 $215,283 +71% 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$4.59 10,000 38,501 2024-03-04 Filing
$4.59 10,000 76,724 2024-03-04 Filing
$5.50 5,000 Officer, Director 66,730 2023-05-30 Filing
$0.00 22,000 Officer, Director 36,920 2022-11-18 Filing
$7.00 6,000 Officer, Director 6,141 2021-05-27 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$0.00 0 Large Shareholder 796,594 2019-06-11 Filing
$2.85 44,982 Large Shareholder 796,594 2019-06-11 Filing
$0.00 0 Large Shareholder 841,576 2019-06-11 Filing
$3.01 2,200 Large Shareholder 841,576 2019-06-11 Filing
$0.00 0 Large Shareholder 843,776 2019-06-11 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 3,852,236 $13,559,871 0%
2. 2,086,500 $7,344,481 0%
3. 1,749,791 $6,159,264 0%
4. 1,306,482 $4,598,817 0.33%
5. 755,845 $2,661,451 0%
News See All